Company Overview and News

7
Coffee Day investors may have to wait for their caffeine kick

2018-09-03 livemint
UK’s Whitbread Plc investors got a caffeine high on Friday, what with its shares rising 14% in London. Investors are seemingly thrilled that Coca-Cola Co. will purchase Costa Ltd, Whitbread’s wholly owned coffee arm, for an enterprise value of $5.1 billion. This translates into about 16 times Costa’s FY18 Ebitda (earnings before interest, tax, depreciation and amortization) and is a surprisingly big premium, analysts have reckoned.
WTB 539436 COFFEEDAY SBUX WTBCF WTBCY

1
India’s Costa Coffee may brew cola wars

2018-09-01 livemint
New Delhi: Coca-Cola Co., the American beverage maker that acquired the British company Costa Ltd for $5.1 billion on Friday, may have to look for a new partner to run Costa Coffee outlets in India.
PEP 539436 COFFEEDAY

 
Coffee Day Enterprises Limited - Shareholders meeting

2018-08-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

 
Coffee Day Enterprises Q1 net down 20% to Rs 21 crore

2018-08-09 moneycontrol
Coffee Day Enterprises, which runs the popular Cafe Coffee Day chain, today reported 20.15 per cent decline in consolidated net profit at Rs 21 crore for the June quarter, 2018-19.
539436 COFFEEDAY

7
Starbucks to enter smaller Indian cities from next fiscal

2018-07-26 livemint
New Delhi: Tata Starbucks Pvt. Ltd, the joint venture between Tata Global Beverages and Starbucks Corp., is looking at smaller Indian cities with population of less than 5 million to open outlets next fiscal year, chief executive officer Sumitro Ghosh said.
TGBL 500800 TGBA TTAZF 539436 COFFEEDAY SBUX TATAGLOBAL TTAEY

 
Coffee Day Enterprises Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-07-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

1
Podcast | Sensex ends at record high, Nifty manages to close above 11K; RIL surges 4%

2018-07-12 moneycontrol
Driven by positive global cues as well as a good start to earnings season, backed by TCS, pushed the markets to fresh records on Thursday. Investors looked to cash in on the bullish momentum as buying was visible across sectors. Having said that, the Street closed off the day's high points.
500325 533271 RELIANCE 539436 COFFEEDAY ASHOKA 533278 HDB 500180 RIGD HDFCBANK CLNDY COALINDIA RLNIY

1
An evening walk down Dalal Street | Sensex ends at record high, Nifty manages to close above 11K; RIL surges 4%

2018-07-12 moneycontrol
Driven by positive global cues as well as a good start to earnings season, backed by TCS, pushed the markets to fresh records on Thursday. Investors looked to cash in on the bullish momentum as buying was visible across sectors. Having said that, the Street closed off the day's high points.
500325 533271 RELIANCE 539436 COFFEEDAY ASHOKA 533278 HDB 500180 RIGD HDFCBANK CLNDY COALINDIA RLNIY

 
Cafe Coffee Day operator surges 3% after arm ties up with UberEats to deliver products

2018-07-12 moneycontrol
Shares of Coffee Day Enterprises, the operator of Café Coffee Day, gained around 3 percent in morning trade after its subsidiary tied up with UberEats to distribute food products.
539436 COFFEEDAY

 
Coffee Day Enterprises Limited - Updates

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

 
Coffee Day Enterprises Q4 profit rises 36% at Rs34.5 crore

2018-05-17 livemint
New Delhi: Coffee Day Enterprises, which runs coffee chain under brand name Cafe Coffee Day, on Thursday reported a 36.36% rise in consolidated net profit at Rs34.5 crore for the quarter ended March 2018.
539436 COFFEEDAY

 
Coffee Day Enterprises Q4 net up 36% at Rs 34.5 cr

2018-05-17 moneycontrol
Coffee Day Enterprises, which runs coffee chain under brand name Cafe Coffee Day, today reported a 36.36 percent rise in consolidated net profit at Rs 34.5 crore for the quarter ended March 2018.
539436 COFFEEDAY

 
Coffee Day Enterprises Limited - Financial Result Updates

2018-05-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

 
Coffee Day Enterprises Limited - Investor Presentation

2018-05-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...